ChromaDex Corporation operates as a bioscience company focusing on healthy aging. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches on nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingredients directly to consumers, as well as to distributors; and develops and commercializes proprietary-based ingredient technologies and supplies these ingredients as raw materials to the manufacturers of consumer products. The company also commercializes NAD+ precursor nicotinamide riboside as the flagship ingredient NIAGEN; NIAGEN as an active ingredient in its consumer products under the TRU NIAGEN name; and IMMULINA, a Braun-type lipoproteins, including spirulina extracts and active compounds, which are used to support human immune function. It also offers analytical reference standards and services comprising supply of products to conduct quality control of raw materials and consumer products in dietary supplements, cosmetics, food and beverages, life sciences, and pharmaceutical industries. The company distributes TRU NIAGEN products direct to consumers through its propriety e-commerce platform TRUNIAGEN.com, Amazon, and other internet marketplaces, as well as specialty retailers and direct healthcare practitioners in the United States. ChromaDex Corporation is headquartered in Los Angeles, California.
The current price of CDXC is $7.87 USD — it has decreased by -0.88% in the past 24 hours. Watch ChromaDex stock price performance more closely on the chart.
What is ChromaDex stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange ChromaDex stocks are traded under the ticker CDXC.
What is ChromaDex revenue for the last year?▼
ChromaDex revenue for the last year amounts to 99.6M USD.
What is ChromaDex net income for the last year?▼
CDXC net income for the last year is 8.55M USD.
How many employees does ChromaDex have?▼
As of April 01, 2026, the company has 104 employees.
In which sector is ChromaDex located?▼
ChromaDex operates in the Health Care sector.
When did ChromaDex complete a stock split?▼
The last stock split for ChromaDex was on April 13, 2016 with a ratio of 1:3.